TCS Recognized as a Leader in Life Sciences BPO Services by Everest Group

PRESS RELEASE

 

TCS Recognized as a Leader in Life Sciences BPO Services by Everest Group

Report Cites Tata Consultancy Services Strong Business Process Capabilities, Global Footprint and Strategic Partnerships as Key Attributes

NEW YORK | MUMBAI, July 25, 2017: Tata Consultancy Services (TCS), (BSE: 532540, NSE: TCS) a leading global IT services, consulting and business solutions organization, has been recognized as a ‘Leader’ for Life Sciences BPO Services by leading advisory and research firm, Everest Group, in its report, ‘Life Sciences BPO – Service Provider Landscape with PEAK MatrixTM Assessment 2017.’ 

The report highlighted TCS’ strong business process capabilities across the board, including end-to-end service capabilities in all Business Process Services value chain segments for Life Sciences, with focus towards Pharmacovigilance and Drug Discovery processes. In addition, TCS is recognized for its highly qualified consultant base, providing it an edge over competitors in drug discovery and clinical and pharmacovigilance services, and a well-diversified client split across the globe.

Everest Group analyzed the capabilities of 13 service providers on the Everest Group PEAK Matrix in the global life sciences sector. The PEAK Matrix is a composite framework that provides an objective, data driven and comparative assessment of life sciences BPO service providers, which are then divided into three categories, Leaders, Major Contenders, and Aspirants, based on market success and delivery capability.

“Clinical Research Organizations’ limited capability to meet changing technology demands has created opportunities for Business Process Services players to expand their offerings, particularly in the drug discovery and clinical research arenas,” said Manu Aggarwal, Practice Director, Everest Group. “TCS’ strength in the medical domain, derived from its robust Pharmacovigilance and regulatory practice, has enabled it to expand its reach into the clinical side, and address changing enterprise buyer needs.”

“Life Sciences customers today seek to accelerate drug discovery and achieve greater operational efficiency while combatting increasing regulation and data safety concerns.  By leveraging our domain expertise augmented by process automation, TCS Life Sciences is enabling customers to re-imagine their business across the life sciences value chain,” said Debashis Ghosh, President - Life Sciences, Healthcare, Government and Energy Business Group, TCS.  “With our consistent focus on digital solutions and development of next-gen platforms, we continue to add value to our customers.”

About TCS Life Sciences
TCS Life Sciences provides top global Life Sciences organizations full service offerings in IT, Consulting, KPO, Infrastructure and Engineering Services, as well as digital solutions using Mobility, Big Data, Analytics, and Cloud. TCS’ rich industry experience, domain expertise and global footprint allows for a seamless partnership with its Life Sciences customers to help them advance clinical trial efficiencies, accelerate drug discovery, accentuate manufacturing productivity, and amplify sales and marketing effectiveness. In addition, TCS has a dedicated Life Sciences Innovation Lab which ensures that its customers have the tools and innovative solutions they need to solve complex business challenges.

About Tata Consultancy Services Ltd. (TCS)

Tata Consultancy Services is an IT servicesconsulting and business solutions organization that delivers real results to global business, ensuring a level of certainty no other firm can match. TCS offers a consulting-led, integrated portfolio of IT, BPS, infrastructure, engineering and assurance services. This is delivered through its unique Global Network Delivery Model™ (GNDM), recognized as the benchmark of excellence in software development. A part of the Tata group, India’s largest industrial conglomerate, TCS has over 387,000 of the world’s best-trained consultants in 46 countries. The company generated consolidated revenues of US $17.58 billion for year ended March 31, 2017 and is listed on the BSE (formerly Bombay Stock Exchange) and the NSE (National Stock Exchange) in India. For more information, visit us at www.tcs.com.

To stay up-to-date on TCS news in North America, follow @TCS_NA.

For TCS global news, follow @TCS_News

TCS Media Contacts

Global

Email: pradipta.bagchi@tcs.com

Phone: +91 22 6778 9999

Europe

Email: ashish.babu@tcs.com

Phone: +31611531246

UK

Email: peter.devery@tcs.com

Phone: +44 20 3155 2421

India

Email: h.ramachandra@tcs.com shamala.p@tcs.com

Phone: +91 22 6778 9078 | +91 22 6778 9081

USA/Canada

Email: b.trounson@tcs.com

Phone: +1 646 313 4594

Asia Pacific

Email: neerja.jetley@tcs.com

Phone: +65-90295944

Australia and New Zealand

Email: darren.rudd@tcs.com

Phone: +61 488 403 013

Latin America

Email: martin.karich@tcs.com

Phone: +569 6170 9013

Nordics

Email: mattias.afgeijerstam@tcs.com

Phone: +46723989188

Japan

Email: douglas.foote@tcs.com

Phone: +81 80-2115-0989